PELTHOS THERAPEUTICS INC (PTHS) Forecast, Price Target & Analyst Ratings

NYSEARCA:PTHS • US1711262048

Current stock price

22 USD
+1.26 (+6.08%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PELTHOS THERAPEUTICS INC (PTHS).

Forecast Snapshot

Consensus Price Target

Price Target
$61.61
+ 180.04% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q1 / 2026
EPS Estimate
-$3.75
Revenue Estimate
11.416M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
83.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$61.61
Upside
+ 180.04%
From current price of $22.00 to mean target of $61.61, Based on 12 analyst forecasts
Low
$50.50
Median
$61.20
High
$78.75

Price Target Revisions

1 Month
-9.39%
3 Months
8.73%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for PTHS. The average price target is 61.61 USD. This implies a price increase of 180.04% is expected in the next year compared to the current price of 22.
The average price target has been revised upward by 8.73% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

PTHS Current Analyst RatingPTHS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

PTHS Historical Analyst RatingsPTHS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -15 -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
83.33%
PTHS was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about PTHS.
In the previous month the buy percentage consensus was at a similar level.
PTHS was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-20OppenheimerMaintains Outperform -> Outperform
2026-03-19HC Wainwright & Co.Reiterate Buy -> Buy
2026-02-27Piper SandlerInitiate Overweight
2026-02-26Roth CapitalMaintains Buy -> Buy
2026-01-26OppenheimerMaintains Outperform -> Outperform
2025-12-03Lake StreetInitiate Buy
2025-12-03HC Wainwright & Co.Initiate Buy
2025-11-25Roth CapitalInitiate Buy
2025-11-14OppenheimerReiterate Outperform -> Outperform
2025-09-02OppenheimerInitiate Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q1 / 2026
EPS Estimate
-$3.75
Revenue Estimate
11.416M
Revenue Q2Q
N/A
EPS Q2Q
-1,168.97%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-0.22%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

The next earnings revenue estimate has been revised downward by 0.22% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2024 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
PTHS revenue by date.PTHS revenue by date.
199.9KN/A
-100.00%		N/AN/AN/A17.53M64.011M
265.15%		111.55M
74.27%		207.69M
86.19%		211.26M
1.72%		247.07M
16.95%		213.45M
-13.61%		221.8M
3.91%		232.27M
4.72%
EBITDA
YoY % growth
PTHS ebitda by date.PTHS ebitda by date.
N/AN/AN/AN/AN/A-17.203B-19.993B
-16.22%		19.065B
195.36%		N/A35.088M45.594M
29.94%		56.508M
23.94%		63.036M
11.55%		70.278M
11.49%
EBIT
YoY % growth
PTHS ebit by date.PTHS ebit by date.
-1.354MN/A
38.03%		N/A
-176.31%		N/A
-196.02%		-7.036M
-2.53%		-35.898M
-410.20%		-38.972M
-8.56%		-4.176M
89.28%		54.8M
1,412.30%		60.758M
10.87%		82.681M
36.08%		60.749M
-26.53%		67.783M
11.58%		74.841M
10.41%
Operating Margin
PTHS operating margin by date.PTHS operating margin by date.
-677.29%N/AN/AN/AN/A-204.78%-60.88%-3.74%26.39%28.76%33.46%28.46%30.56%32.22%
EPS
YoY % growth
PTHS eps by date.PTHS eps by date.
N/AN/AN/AN/A-13.26-18.17
-37.03%		-9.56
47.40%		0.81
108.47%		4.50
455.88%		5.12
13.72%		6.79
32.65%		8.69
28.07%		9.35
7.63%		9.88
5.67%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-3.75
-1,168.97%		-0.93
82.75%		-0.56
89.51%		-0.56
72.36%
Revenue
Q2Q % growth		11.416M11.159M14.181M
91.48%		15.17M
61.57%
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-13.358M
-628.37%		-7.141M
-121.06%		-4.362M
71.61%		-3.482M
76.78%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

PTHS Yearly Revenue VS EstimatesPTHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2025 2026 2027 2028 2029 2030 2031 2032 2033 50M 100M 150M 200M
PTHS Yearly EPS VS EstimatesPTHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5 -10 -15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

PELTHOS THERAPEUTICS INC / PTHS Forecast FAQ

What is the average price target for PELTHOS THERAPEUTICS INC (PTHS) stock?

12 analysts have analysed PTHS and the average price target is 61.61 USD. This implies a price increase of 180.04% is expected in the next year compared to the current price of 22.

What are the consensus estimates for PELTHOS THERAPEUTICS INC (PTHS) next earnings?

The consensus EPS estimate for the next earnings of PELTHOS THERAPEUTICS INC (PTHS) is -3.75 USD and the consensus revenue estimate is 11.42M USD.

What is the number of analysts for PTHS stock?

The number of analysts covering PELTHOS THERAPEUTICS INC (PTHS) is 12.